[1] Wendling U,Paul L,van der Zee R,et al.A conserved mycobacterial heat shock protein(hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue.J Immunol,2000,164(5):2711-2717. [2] Wells AD,Malkovsky M.Heat shock proteins,tumor immunogenicity and antigen presentation:an integrated view.Immunol Today,2000,21(3):129-132. [3] 樊建勇,杨慧兰,王捷.Hsp70-HSV-2gD融合蛋白疫苗阳离子脂质体的制备.中国麻风皮肤病杂志,2006,22(11):888-890. [4] Subak-Sharpe JH,Dargan DJ.HSV molecular biology:general aspects of herpes simplex virus molecular biology.Virus Genes,1998,16(3):239-251. [5] Whitley RJ,Roizman B.Herpes simplex virus infections.Lancet,2001,357(9267):1513-1518. [6] 韩双艳,杨慧兰,王捷,等.单纯疱疹病毒2型DNA疫苗对豚鼠抗病毒感染的研究.中华皮肤科杂志,2003,36(12):708-710. [7] Dupuis M,McDonald DM,Ott G.Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice.Vaccine,1999,18(5-6):434-439. [8] Basu S,Binder RJ,Ramalingam T,et al.CD91 is a common receptor for heat shock proteins gp96,hsp90,hsp70,and calreticulin.Immunity,2001,14(3):303-313. [9] Moroi Y,Mayhew M,Trcka J,et al.Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70.Proc Natl Acad Sci U S A,2000,97(7):3485-3490. |